Sulfasalazine delayed release tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; b) for the prolongation of the remission period between acute attacks of ulcerative colitis; c) in the treatment of patients with rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs (e.g.…
From the U.S. FDA-approved label for Sulfasalazine. Full label: DailyMed.
Sulfasalazine delayed release tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; b) for the prolongation of the remission period between acute attacks of ulcerative colitis; c) in the treatment of patients with rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs (e.g., an insufficient therapeutic response to, or intolerance of, an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs); and d) in the treatment of pediatric patients with polyarticular-course 1 juvenile rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs.
From the U.S. FDA-approved label for Sulfasalazine. Full label: DailyMed.
The dosage of sulfasalazine delayed release tablets should be adjusted to each individual's response and tolerance. Patients should be instructed to take sulfasalazine delayed release tablets in evenly divided doses, preferably after meals, and to swallow the tablets whole. Ulcerative Colitis Initial Therapy: Adults: 3 to 4 g daily in evenly divided doses with dosage intervals not exceeding eight hours.
Directions from the U.S. FDA-approved label for Sulfasalazine — your doctor or pharmacist may advise differently.
Sulfasalazine delayed release tablets are contraindicated in: Hypersensitivity to sulfasalazine, its metabolites, sulfonamides or salicylates, Patients with intestinal or urinary obstruction, Patients with porphyria, as the sulfonamides have been reported to precipitate an acute attack.
Excerpt from the U.S. FDA-approved label for Sulfasalazine. Talk to a pharmacist or doctor before use.
Hepatic, Renal, and Hematologic Toxicity or Other Conditions Only after critical appraisal should sulfasalazine delayed release tablets be given to patients with hepatic or renal damage or blood dyscrasias. Deaths associated with the administration of sulfasalazine have been reported from hypersensitivity reactions, agranulocytosis, aplastic anemia, other blood dyscrasias, renal and liver damage, irreversible neuromuscular and central nervous system changes, and fibrosing alveolitis.
Warnings and precautions excerpt from the U.S. FDA-approved label for Sulfasalazine — not a complete list. Talk to a pharmacist or doctor before use.
The most common adverse reactions associated with sulfasalazine in ulcerative colitis are anorexia, headache, nausea, vomiting, gastric distress, and apparently reversible oligospermia. These occur in about one-third of the patients. Less frequent adverse reactions are pruritus, urticaria, rash, fever, Heinz body anemia, hemolytic anemia, and cyanosis, which may occur at a frequency of 1 in 30 patients or less.
Excerpt from the U.S. FDA-approved label for Sulfasalazine — not a complete list. Talk to a pharmacist or doctor about side effects.
7 brands · 6 makers in the NepalDoc catalog — see the full Sulfasalazine guide →
Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F).
Storage information from the U.S. FDA-approved label for Sulfasalazine.
What is Sulfaz?
Sulfaz 500mg Tablet is a Sulfasalazine medicine made by Time Pharmaceuticals Pvt. Ltd. It comes as 500mg Tablet.
What is the generic name of Sulfaz?
The generic name of Sulfaz is Sulfasalazine.
Which brands of Sulfasalazine are available in Nepal?
7 brands of Sulfasalazine are listed in the NepalDoc catalog, from 6 makers — including Corzin 500mg Tablet, Saaz 500mg Tablet, Saaz 500mg Tablet, Salazo 500mg Tablet, Salzin 500mg Tablet, Sazo 500mg Tablet.
What are the side effects of Sulfasalazine?
The most common adverse reactions associated with sulfasalazine in ulcerative colitis are anorexia, headache, nausea, vomiting, gastric distress, and apparently reversible oligospermia. These occur in about one-third of the patients.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
